Medicinova (MNOV) Accumulated Depreciation (2011 - 2025)
Medicinova (MNOV) posted quarterly Accumulated Depreciation of $422809.0 for Q4 2025, up 4.98% year-over-year from $402734.0 in Q4 2024, and up 4.98% quarter-over-quarter from $402734.0 in Q4 2024.
Medicinova (MNOV) Accumulated Depreciation (2011 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Accumulated Depreciation for 15 consecutive years, with $422809.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 4.98% year-over-year to $422809.0; the TTM figure through Dec 2025 stood at $422809.0 (up 4.98% YoY), while the FY2025 annual figure was $422809.0, up 4.98% from the prior year.
- Accumulated Depreciation climbed to $422809.0 in Q4 2025 per MNOV's latest filing, from $402734.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $443513.0 in Q4 2023 and bottomed at $402734.0 in Q4 2024.
- Historically, Accumulated Depreciation has averaged $425411.8 across 5 years, with a median of $425203.0 in 2021.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation retreated 18.8% — and 2025, when it advanced 4.98%.
- Medicinova's Accumulated Depreciation stood at $425203.0 in 2021, then grew by 1.79% to $432800.0 in 2022, then advanced by 2.48% to $443513.0 in 2023, then slipped by 9.19% to $402734.0 in 2024, then increased by 4.98% to $422809.0 in 2025.
- Business Quant data shows MNOV's Accumulated Depreciation at $422809.0 in Q4 2025, $402734.0 in Q4 2024, and $443513.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 422,809.00 |
| Dec 31, 2024 | 402,734.00 |
| Dec 31, 2023 | 443,513.00 |
| Dec 31, 2022 | 432,800.00 |
| Dec 31, 2021 | 425,203.00 |
| Dec 31, 2020 | 523,617.00 |
| Dec 31, 2019 | 497,859.00 |
| Dec 31, 2018 | 483,528.00 |
| Dec 31, 2017 | 471,715.00 |
| Dec 31, 2016 | 499,400.00 |
| Dec 31, 2015 | 483,242.00 |
| Dec 31, 2014 | 461,948.00 |
| Dec 31, 2013 | 431,193.00 |
| Dec 31, 2012 | 672,301.00 |
| Dec 31, 2011 | 925,935.00 |